동향
Home > DB > 동향
| Repackaging of Certain Human Drug Products by Pharmacies and Outsourcing Facilities | |||
|---|---|---|---|
| 분류 | GMP, Guidance | 조회 | 2723 |
| 발행년도 | 2015 | 등록일 | 2015-10-02 |
| 출처 | FDA (바로가기) | ||
|
This guidance sets forth the Food and Drug Administration’s (“FDA” or “the Agency”) policy regarding repackaging by state-licensed pharmacies, Federal facilities, and facilities that register with FDA as outsourcing facilities under section 503B of the Federal Food, Drug, and Cosmetic Act (FD&C Act or the Act).
(후략)
|
|||
|
|
 이전글 |
Mixing, Diluting, or Repackiaging Biological Products Outside the Scope of an Approved Biologics |
|---|---|
 다음글 |
Request for Quality Metrics Guidance for Industry |
